Tweet
<img alt="" height="1" width="1" />
Onyx Treatment Fights Cancer With Few Side Effects
Bloomberg
Dec. 7 (Bloomberg) -- Onyx Pharmaceuticals Inc.'s carfilzomib, acquired with the November purchase of Proteolix Inc., worked in patients with multiple myeloma, a study found. The experimental drug also helped reduce ...
Onyx drug shows promise in multiple myeloma studyReuters
Onyx Pharma Announces Phase 1b/2 Interim Results For Carfilzomib - UpdateRTT News
Onyx Pharmaceuticals (ONXX): Upside Expected $42Benzinga
FierceBiotech -CombiChem.net -PR Newswire (press release)
all 50 news articles »
More...